Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001065436 | SCV001230394 | pathogenic | not provided | 2024-11-22 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 7 of the ABCA4 gene. It does not directly change the encoded amino acid sequence of the ABCA4 protein. This variant is present in population databases (rs529598960, gnomAD 0.06%). This variant has been observed in individual(s) with clinical features of ABCA4-related retinal dystropy (PMID: 23982839, 25082829, 25082885, 28327576). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 859348). Studies have shown that this variant alters ABCA4 gene expression (PMID: 29162642). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001074005 | SCV001239571 | pathogenic | Retinal dystrophy | 2018-10-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001065436 | SCV001844836 | pathogenic | not provided | 2024-11-13 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23982839, 25082885, 25082829, 29925512, 29162642, 36648511, 32037395, 35089312, 28327576, 31964843, 35120629, 33258285, 32307445, 38219857) |
Revvity Omics, |
RCV001065436 | SCV003828219 | likely pathogenic | not provided | 2022-06-22 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001074005 | SCV005068647 | likely pathogenic | Retinal dystrophy | 2021-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005036373 | SCV005656458 | likely pathogenic | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2024-05-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004536128 | SCV004711119 | likely benign | ABCA4-related disorder | 2019-06-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |